Abstract

Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call